Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wood-loving magic mushrooms from Australia are saprotrophic invaders in the Northern Hemisphere.

Fungal systematics and evolution·2025
Same author

Chromosome breakpoint distribution of damage induced in peripheral blood lymphocytes by densely ionizing radiation.

International journal of radiation biology·2006
Same author

Increased complexity of radiation-induced chromosome aberrations consistent with a mechanism of sequential formation.

Cytogenetic and genome research·2005
Same author

X-ray-induced simple, pseudosimple and complex exchanges involving two distinctly painted chromosomes.

International journal of radiation biology·1999
Same author

An investigation of LET 'finger-prints' in Tradescantia.

Mutation research·1998
Same author

Effectiveness of 0.28 keV carbon K ultrasoft X-rays at producing simple and complex chromosome exchanges in human fibroblasts in vitro detected using FISH.

International journal of radiation biology·1998

Related Experiment Video

Updated: Jul 26, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Cancer survival in the USA, 1973-1990: a statistical analysis

D G Papworth1, R A Lloyd

  • 1MRC Radiation and Genome Stability Unit, Didcot, Oxfordshire, UK.

British Journal of Cancer
|December 4, 1998
PubMed
Summary

This study introduces a model to estimate median survival time (MST) using National Cancer Institute

Area of Science:

  • Oncology
  • Biostatistics
  • Cancer Research

Background:

  • Cancer survival rates are commonly reported using 5-year relative survival rates (RSRs).
  • Estimating survival trends accurately is crucial for understanding cancer patient outcomes.
  • The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program provides extensive cancer data.

Purpose of the Study:

  • To develop and validate a statistical model for estimating median survival time (MST) in cancer patients.
  • To compare the utility of MST as a survival metric against traditional 5-year relative survival rates (RSRs).
  • To provide a method for assessing cancer survival trends across different calendar years.

Main Methods:

  • Fitting a statistical model to relative survival rates from the NCI SEER database.

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jul 26, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

  • Utilizing the fitted model to calculate and project median survival times.
  • Comparative analysis of MST and RSR metrics.

    • Main Results:

    • The developed model effectively fits relative survival data from the SEER program.
    • Median survival time (MST) can be reliably estimated for any calendar year using this model.
    • MST is proposed as a more sensitive indicator of survival, particularly for cancers with shorter survival durations.

    Conclusions:

    • The proposed model offers a valuable tool for estimating cancer patient median survival times.
    • Median survival time (MST) provides a more nuanced understanding of survival trends than 5-year relative survival rates (RSRs).
    • This approach enhances the assessment of cancer prognosis and treatment effectiveness over time.